Clinical Trial Update: An Observational Study to Evaluate Tolerability of Canagliflozin and Sulphonylurea in Type 2 Diabetes Patients During Ramadan

View source ↗

Summary

This completed observational study evaluated tolerability of combining canagliflozin with a sulphonylurea in adults with type 2 diabetes during Ramadan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Canagliflozin (canagliflozin)
• Sulphonylurea (sulphonylurea)

Snippet

Sponsor: Janssen-Cilag International NV | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED